BIT 3.85% 2.7¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-32

  1. 2,875 Posts.
    lightbulb Created with Sketch. 303
    This study was a particularly complex and time-consuming trial. The results reported here are preliminary, and ongoing analysis of this BIT225-011 trial and the BIT225-010 HIV-1 trial in a treatment-naïve population will be reported when complete.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $24.36M
Open High Low Value Volume
2.7¢ 2.8¢ 2.6¢ $21.78K 807.4K

Buyers (Bids)

No. Vol. Price($)
2 138461 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 194761 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.